VA
RARE icon

Vident Advisory’s Ultragenyx Pharmaceutical RARE Stock Holding History

Vident Advisory’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-4,487
Closed -$215K – 1386
2023
Q4 		$215K Buy
+4,487
New +$215K 0.01% 1182